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Hand contact eczema could blind twice
Machado, D; Pereira, C; Loureiro, G; Tavares, B;
Calado, G; Ribeiro, C; Chieira, C
Coimbra University Hospitals, Immunoallergology
Department, Coimbra, Portugal
Background: We report a case of a
38 years old blind female since she was
15 years old after retinal detachment. In
the last 14 months she started erythema-
tous skin of both hands, as well as severe
lesions of erythematous licheniﬁed plaques
alternating with vesicles, particularly on
the top of ﬁngers. She described a dreadful
itching and progressive loss of sensitivity
that avoided Braille reading. No other
lesions were observed in other skin local-
izations. Symptoms were only partially
controlled with local and systemic steroid
treatment without complete remission of
skin lesions. Previous allergic persistent
moderate/severe rhinitis to Dermatophago-
ides pteronyssinus was diagnosed. She was
submitted to European standard epicutane-
ous patch test that demonstrated unspeciﬁc
reactivity to carba mix and ethylenedia-
mine dihydrochloride. The complete
removal and strictly eviction of these
offending agents did not result on clinical
control. A carefully evaluation of patient’s
routine showed the use of woods on equip-
ment to write, walking stick, door handles
and the diary use of the piano in teaching.
Methods: After screening of the woods
that were present on her daily contact,
Swietenia mahogani, Pinus monticola, Chlo-
rophora excelsa, Jugulans nigra, Gosweilero-
dendron balsamiferum, Fagus sylvatic and
Quercus robur were identiﬁed. We per-
formed patch test with these dust wood in
nature (10% in petrolatum). These were
left in place for 48 h. Readings were per-
formed 1 h after removal (48 h) and at
72 h.
Results: Patch tests with Gosweilerodendron
balsamiferum, Fagus sylvatic and Quercus
robur were positive (++). The 72 h read-
ing conﬁrmed the persistence of lesions.
The same tests carried out in two healthy
subjects and in two nickel contact dermati-
tis patients were negative to all wood
extracts.
Discussion: The exhaustive investigation of
further potential contact allergens besides
common standards allowed the diagnosis
of contact eczema to woods. After the
complete removal of numerous quotidian
objects, a total remission of the skin
lesions was observed. The speciﬁc diagnosis
was essential to propose precise measures
that provided recovering of quality of live
recovering, namely preserving the handvi-
sion.
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Autoantibodies associated with Helicob-
acter pylori infection in chronic urticaria
Duca, L1; Anghel, M2; Cazacu, S2; Gorgon, P3
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ogy, Brasov, Romania; 2Brasov County Hospital, Clinical
Immunology Laboratory, Brasov, Romania; 3Hiperdia SA,
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Background: There is evidence supporting
a correlation between Th-1 response and
development of Helicobacter pylori (HP)-
associated autoimmune disease less evalu-
ated in chronic urticaria.
Aims: Incidence and evolution of autoanti-
bodies associated with H. pylori infection
in chronic urticaria (CU).
Methods: Patients with CU, initial evalu-
ated in a prospective study for HP infec-
tion (Antigen determination in stool with
Immunochromatographic Assay) and for
associated autoantibodies (anti-thyroglobu-
lin, anti-thyroperoxidase, anti-smooth mus-
cle (ASMA), anti-nuclear (ANA), anti-liver
kidney microsomal (LKM1), P-ANCA and
cryoglobulins). Patients separated in two
groups: A – Ag HP present and B without
HP. After 6 month and speciﬁc treatment
for HP eradication and CU, patients were
re-evaluated for HP infection and serologic
outcome for autoantibodies in both
groups. Other causes for autoimmunity
were excluded. Statistics by Chi test and
Pearson correlation test.
Results: Fifty-four patients were included:
mean age 35.7 ± 12.74 years, 32 (59.25%)
female, mean UAS 4.70 ± 1.15. HP Ag
detected in 35 (64.81%) patients-group A,
19 (35.19%) patients without HP – group
B. ANA present in 17 (48.57%) pts.
in group A,4 (21.05%) in group B
(P < 0.05), anti-thyroglobulin in 9
(25.71%) pts. in group A, 0 pts. in group
B (P < 0.05), anti-thyroperoxidase 13
(37.14%) pts. in group A, 4 (21.05%) in
group B, cryoglobulins 19 (54.29%) pts. in
group A, 6 (31.58%) pts. in group B,
pANCA in 8 (22.86%) pts. in group A, 0
pts. in group B (P < 0.05), ASMA, AMA
in 2 (5.71%) pts. and LKM1 in 1 (2.86%)
pts. in group A, 0 pts in group B.
With Pearson correlation test infection
with HP strongly correlated with ANA
(R = 0.0727, P = 0.049), anti-thyroglobu-
lin (R = 0.1086, P = 0.015), pANCA
(R = 0.0944, P = 0.024). After 6 months
and treatment of HP infection the eradica-
tion ratio was 88.57% (31 pts.) associated
with 96.77% improvement/remission of
CU comparing with 63.15% in group B
(P < 0.001). HP infection eradication
correlated with serological resolution for:
anti-thyroglobulin Ab (R = 0.1017, P =
0.019), ANA (R = 0.1225, P = 0.009),
pANCA (R = 0.6934, P < 0.001).
Conclusions: Incidence of ANA, anti thy-
roglobulin Ab and pANCA is statistically
signiﬁcant increased in group of CU asso-
ciated with HP infection comparing with
control group. Serologic outcome of
autoantibodies and clinical resolution of
CU strongly correlated with HP eradica-
tion suggesting implication of persistent
infection in autoimmune mechanisms in a
particular type of CU.
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Hereditary angioedema type I patients
with anti-C1-INH antibodies can be
effectively treated with icatibant
Bouillet, L1; Boccon-Gibod, I1; Ponard, D1; Dumestre-
Perard, C2; Cesbron, J1; Massot, C1
1Grenoble University Hospital, Angioedema National
Reference Center, Grenoble, France; 2CHRU Hoˆpital
sud, Laboratory of Immunology, Grenoble, France
Background: Hereditary angioedema
(HAE) is a rare, autosomal dominant
genetic disease (incidence of 1 in 50 000).
The biological mediator implicated in the
pathophysiology of symptoms is bradyki-
nin, which binds to the bradykinin B2
receptor on endothelial cells in the blood
vessels. Laryngeal oedema is the principal
cause of death in patients with HAE
(approximately 30% mortality if laryngeal
oedema is not treated appropriately). The
morbidity of the disease is associated with
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